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Introduction
Menstrual migraine is a big challenge for the migraine
expert. Severity and duration of hormonal stimulation
determines the gravity and duration of menstrual attack.
Various prevention therapy try to alleviate these
attacks, usually long half-life triptans and-or anti-inflam-
matory drugs, combined with caffeine, magnesium, but
however is very difficult to find the right drug in parti-
cular in women with uterine fibroids or endometriosis.
Aims
To support this limited class of patients, we considered
to use the Oxycodone/Naloxone Extended Release (O/
N-ER) for its favourable mechanism of action on neuro-
pathic pain, long half life and well documented gastroin-
testinal safety. Although the drug has an indication for
chronic pain, many reports in literature support its use
in acute pain.
Methods
Recruitment is only for patients non-responders to classi-
cal preventive therapy. Will be collected informed consent,
headache diary and a satisfaction questionnaire on ther-
apy, those data will compared with the one recorded in
the previous quarter, pharmacoeconomic analysis will
provided.
Patients will use O/N-ER exclusively for menstrual
attacks and for three consecutive periods, with the pos-
sibility of use a triptan at the start of attack followed by
O/N-ER bid for 3-5 days.
Results
Of the 8 patients that have completed the study (12
patients are ongoing in the trial), 70% of the patients
showed a mean reduction in intensity of attacks from 8 to
4 on a NRS scale, grade of satisfaction was 8/10, without
significant side effects. More data will come from the ana-
lysis of the entire group of the enrolled patients.
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